English
Home > Products > H-ALA-ALA-OME HCL

China H-ALA-ALA-OME HCL Factory

We will devote ourselves to giving our esteemed buyers using the most enthusiastically thoughtful services for H-ALA-ALA-OME HCL,CAS NO 41036-19-5,41036-19-5, You would not have any communication problem with us. We sincerely welcome clients all over the world to get hold of us for organization cooperation.
H-ALA-ALA-OME HCL, We can meet the various needs of customers at home and abroad. We welcome new and old customers to come to consult & negotiate with us. Your satisfaction is our motivation! Let us work together to write a brilliant new chapter!

Related Products

Hot Products

  • 2-Morpholinoethanol

    2-Morpholinoethanol

    Product Name:2-Morpholinoethanol
    Molecular Weight:131.17
    CAS Registry Number:622-40-2
  • L-xylose

    L-xylose

    Product Name:L-xylose
    Molecular Formula:C5H10O5
    Molecular Weight:150.13
    CAS Registry Number:609-06-3
  • 4-Bromobiphenyl

    4-Bromobiphenyl

    Product Name:4-Bromobiphenyl
    Molecular Formula:C12H9Br
    Molecular Weight:233.1
    CAS Registry Number:92-66-0
  • Teneligliptin Hydrobromide

    Teneligliptin Hydrobromide

    Product Name:Teneligliptin Hydrobromide
    Molecular Formula:C22H31BrN6OS
    Molecular Weight;507.5
    CAS Registry Number;906093-29-6
  • Ivermectin

    Ivermectin

    Product Name:Ivermectin
    Molecular Formula:C48H74O14
    Molecular Weight;875.09
    CAS Registry Number;70288-86-7
  • Fosaprepitant dimeglumine

    Fosaprepitant dimeglumine

    Product Name:Fosaprepitant dimeglumine
    Molecular Formula:C30H39F7N5O11P
    Molecular Weight;809.63
    CAS Registry Number;265121-04-8
  • Related Blog
  • Reviews

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept